Anti-α4 antibody treatment blocks virus traffic to the brain and gut early, and stabilizes CNS injury late in infection - Test2 - elhamkhani - TriplyDB

Anti-α4 antibody treatment blocks virus traffic to the brain and gut early, and stabilizes CNS injury late in infection

Anti-α4 antibody treatment blocks virus traffic to the brain and gut early, and stabilizes CNS injury late in infection

http://www.wikidata.org/entity/Q27322602

about

Targeting the Brain Reservoirs: Toward an HIV Cure Insights into end-organ injury in HIV infection: dynamics of monocyte trafficking to the brain in SIV encephalitis.SIV encephalitis lesions are composed of CD163(+) macrophages present in the central nervous system during early SIV infection and SIV-positive macrophages recruited terminally with AIDS.Anti-α4 Integrin Antibody Blocks Monocyte/Macrophage Traffic to the Heart and Decreases Cardiac Pathology in a SIV Infection Model of AIDS.Loss of CCR2 expressing non-classical monocytes are associated with cognitive impairment in antiretroviral therapy-naïve HIV-infected Thais.Monocyte/macrophages and their role in HIV neuropathogenesis.α4-Integrin Antibody Treatment Blocks Monocyte/Macrophage Traffic to, Vascular Cell Adhesion Molecule-1 Expression in, and Pathology of the Dorsal Root Ganglia in an SIV Macaque Model of HIV-Peripheral Neuropathy.Regional astrocyte IFN signaling restricts pathogenesis during neurotropic viral infection Neuropathogenesis of HIV: from initial neuroinvasion to HIV-associated neurocognitive disorder (HAND)Frontline Science: CXCR7 mediates CD14(+)CD16(+) monocyte transmigration across the blood brain barrier: a potential therapeutic target for NeuroAIDS.Non-human primate models of SIV infection and CNS neuropathology.Treating HIV Infection in the Central Nervous System.Sonic Hedgehog mimetic prevents leukocyte infiltration into the CNS during acute HIV infection.Modeling brain lentiviral infections during antiretroviral therapy in AIDS.Macrophage Polarization in AIDS: Dynamic Interface between Anti-Viral and Anti-Inflammatory Macrophages during Acute and Chronic Infection.Mechanisms of CNS Viral Seeding by HIV+ CD14+ CD16+ Monocytes: Establishment and Reseeding of Viral Reservoirs Contributing to HIV-Associated Neurocognitive Disorders.HIV-infected cannabis users have lower circulating CD16+ monocytes and IP-10 levels compared to non-using HIV patients.Neurological Complications of HIV Infection.

P2860

Q28075694-67AF9A80-A1A4-46E0-8CC8-E891225C5084 Q35669007-C380679C-5ACF-443A-BF4D-3C7FF57D41BD Q35669020-9E2BC8A0-A11B-4F06-B1EE-01466278639A Q36168754-2BC65826-F11A-41C1-92F9-4B4D4BDACBEC Q36250020-7A460D6A-D48E-4C62-B0E9-8739455C9B6F Q36991666-0336A67D-346C-4E24-B092-93D4F833D9AF Q37057132-8FE3F2E7-CBF5-4CF0-9FC4-0360B1553DFF Q37672112-808C4549-9F35-446F-8148-7DEA2A687AEF Q38258410-C107271B-45CF-4EBE-AF77-8B6EC4C15EE2 Q38654347-E5F7833D-45A7-4A75-9595-37965C00394C Q38932858-0FBE311A-95A5-4EC8-8C94-7723F7E75FFB Q39077816-5A8B5F05-E9AE-4D81-B4E9-223930A885DC Q40065929-B12C6431-7FA2-460A-A537-57F8B5F59CD2 Q40198639-66D5EC85-F677-49CA-9C7E-30E8B094B5FC Q40937611-234CBD79-0550-4F0A-8F4C-8A7FD152F253 Q42638904-27CBEBEF-DDBE-4F81-8C72-276C2DE66740 Q47342684-D367BB6C-108D-426C-8B04-6F37D697F056 Q52774286-8EB751FB-6BB9-4284-96F5-E6EA51D35850

P2860

Anti-α4 antibody treatment blocks virus traffic to the brain and gut early, and stabilizes CNS injury late in infection

http://www.wikidata.org/entity/Q27322602

description

2014 nî lūn-bûn

@nan

2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Anti-α4 antibody treatment blo ...... s CNS injury late in infection

@ast

Anti-α4 antibody treatment blo ...... s CNS injury late in infection

@en

Anti-α4 antibody treatment blo ...... s CNS injury late in infection

@nl

type

label

Anti-α4 antibody treatment blo ...... s CNS injury late in infection

@ast

Anti-α4 antibody treatment blo ...... s CNS injury late in infection

@en

Anti-α4 antibody treatment blo ...... s CNS injury late in infection

@nl

prefLabel

Anti-α4 antibody treatment blo ...... s CNS injury late in infection

@ast

Anti-α4 antibody treatment blo ...... s CNS injury late in infection

@en

Anti-α4 antibody treatment blo ...... s CNS injury late in infection

@nl

P1433

Q27322602-4AF42EDA-5EA4-4F13-BBA5-145EE6DAD5DA

P1476

Q27322602-EC710610-0CC7-4403-AD53-944E742C67B1

P2093

Q27322602-02DB8FA3-32BB-4676-85B5-5674FBC51FE1

Q27322602-08743ACD-0E3E-4ACB-A816-6D4B30D78697

Q27322602-4412FE58-9BE2-431D-9B24-78A6DBE8753D

Q27322602-74719022-F329-4A20-B04E-96526CAC9841

Q27322602-9465E321-EF22-4F7F-9D48-38FC9A93E89B

Q27322602-B34A8C5F-F6E1-42CF-9C86-B8B03ADD2440

Q27322602-C87B0E60-C090-4823-8E40-FEA1F37BC920

Q27322602-F1DB9853-3A0F-46F1-B984-0D4C916CD33F

P2860

Q27322602-0457CBF2-1BB6-4066-99B9-7678399415CC

Q27322602-15ACA758-D155-4CA2-B08D-808ED6423A80

Q27322602-2A384BB1-104A-471A-A0FB-69A73371B1B8

Q27322602-2B4238EC-FDFF-4EC5-8E98-7CF2B855CA6F

Q27322602-2BC35371-767B-4127-8D26-A84BD2EAF0E2

Q27322602-2CFBF963-1D14-4A4C-B023-2F2F5FB8E10E

Q27322602-31AEBFE6-3452-459E-87A8-D37EB5BE24B2

Q27322602-348A38AE-3D78-40E3-B208-C5CE35B8A04C

Q27322602-39A88BA0-2052-4243-A20A-BA61ADA481D2

Q27322602-3A815A67-87EA-441C-ACB1-CF8437B0F01A

P304

Q27322602-6F9BD1E8-0F12-4520-9485-F6FD21C2C175

P31

Q27322602-0E9D849F-7F79-4FA3-B50A-74E1FF855805

P3181

Q27322602-DBC3EE4E-E7CC-43EF-8350-3EFC226E708A

P356

Q27322602-AF5D6C97-F536-4E4F-A6D7-B14AB5E1DE91

P407

Q27322602-B8A196B4-9539-45D6-9717-C38AC7C85776

P433

Q27322602-C78CD09B-EF37-476E-88A7-EA33D4EA68A6

P478

Q27322602-635CFB0C-7D82-4583-9DB5-090AD8211820

P50

Q27322602-91785F90-59ED-438A-BEB0-295CC8A44B13

Q27322602-DAE8B70B-23CE-4B31-B0BC-3C18F9D051A6

P577

Q27322602-4F62DE43-E581-41AB-8427-F196E32C2DE5

P5875

Q27322602-432F9117-3E0E-4517-B62B-EE1879EEE324

P698

Q27322602-CF362485-2A34-42F6-A72B-3F14D5D79999

P921

Q27322602-9EA4E9D7-06A4-4BE9-9D79-25E85A459664

Q27322602-A4779929-FBC2-4A3B-BDEE-0FC90C5DB687

P932

Q27322602-8BAFB1FE-B200-4DCE-BF01-F370FAA87FDE

P3181

P356

JOURNAL.PPAT.1004533

P1433

P1476

Anti-α4 antibody treatment blo ...... s CNS injury late in infection

@en

P2093

Andrew D Miller

http://www.w3.org/2001/XMLSchema#string

Eva-Maria Ratai

http://www.w3.org/2001/XMLSchema#string

Jennifer H Campbell

http://www.w3.org/2001/XMLSchema#string

Kenneth C Williams

http://www.w3.org/2001/XMLSchema#string

Marco Salemi

http://www.w3.org/2001/XMLSchema#string

Patrick Autissier

http://www.w3.org/2001/XMLSchema#string

R Gilberto González

http://www.w3.org/2001/XMLSchema#string

Tricia H Burdo

http://www.w3.org/2001/XMLSchema#string

P2860

CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract

Natalizumab Induction and Maintenance Therapy for Crohn's Disease

Microbial translocation is a cause of systemic immune activation in chronic HIV infection

HIV-1 envelope protein binds to and signals through integrin α4β7, the gut mucosal homing receptor for peripheral T cells

A prospective longitudinal in vivo 1H MR spectroscopy study of the SIV/macaque model of neuroAIDS

How Natalizumab Binds and Antagonizes 4 Integrins

Natalizumab for active Crohn's disease

The neuropathogenesis of AIDS

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes

P304

e1004533

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3239501

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PPAT.1004533

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-12-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

269689095

http://www.w3.org/2001/XMLSchema#string

P698

25502752

http://www.w3.org/2001/XMLSchema#string

P921

P932

4263764

http://www.w3.org/2001/XMLSchema#string